Colostrum is an exceptional nutritional substance, produced by mothers for their newborns, that supports and nourishes the immune system. It provides a perfect combination of immune and growth factors including immunoglobulins, lactoferrin and insulin-like growth factor 1 (IGF-1), amino acids and other important nutrients. For centuries colostrum has been used by most cultures for healing and wellness. Now with the latest research and technology, quality colostrum can be produced with precision to ensure a pure and potent product.
Serving Size:˙˙ One vegetarian capsule Servings Per Container:˙˙90
Tegricel 575 mg ˙˙(Proprietary Blend of Colostrum Growth Factors)
Other Ingredients: Vegetable cellulose. **Tegricel product does contain lactose. It contains roughly around 9-9.5% lactose which per capsule (about 52-55 mg). This small amount is not removed because it would require the potential denaturazation of the active compounds. If someone is extremely lactose intolerant they may have an issue but in most cases we have not seen this to be a problem.
Recommended Use As a dietary supplement, take one capsule daily or as directed by your health care practitioner.
Tegricel? (patent pending) is a novel nutriceutical designed to enhance general immune function and to help reduce the annoying and sometimes debilitating effects of Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD), including Crohn?s, Celiac and Ulcerative Colitis. It has been suggested to heal and repair damaged tissue from the use of NSAID?s. Tegricel? is also beneficial in other conditions that cause intestinal damage.
What Makes Tegricel? Colostrum Different All Tegricel? Colostrum comes from cattle raised in the United States of America and is produced from healthy, nutritionally-supplemented cows on USDA and FDA certified dairy farms. These cattle are carefully fed a scientifically-designed diet that contains the proper balance of legumes and grasses along with minerals and trace minerals to ensure consistently high potency colostrum.
Colostrum has been shown in studies to:
Enhance the Digestive System
Build Lean Body Mass
Support the Immune System
Improve Vitality and Athletic Performance
Stimulate the Normal Growth, Regeneration and Repair of Muscle
Repair Skin Collagen
Repair Bone Cartilage and Nerve Tissue
HPLC High Performance Liquid Chromotography is a technique used in biotechnological research as well as for the pharmaceutical and nutriceutical industry. Modern HPLC has many applications including separation, identification, purification, and quantification of various compounds. HPLC is used to perform the optimum analysis of compounds in each batch of colostrum to ensure efficacy.
RPF?Repair And Protection Factor A novel (patent pending) analytical method that allows for the evaluation of a product's bioactive properties as it relates to the repair of damaged cells and the protection of healthy cells.
Tegricel? has an RPF Score greater than 3 times the leading New Zealand colostrum supplier and has an RPF Score greater than 2 times that of other leading colostrum products from Australia.
Growth Factors: Proteins that bind to receptors on the cell surface with the primary result of activating cellular proliferation and/or differentiation.
Immunoglobulins: Also known as antibodies, their job is to neutralize antigens, activate complement and promote leukocyte-dependent destruction of microbes.
Interferon-y: Its functions are important in cell-mediated immunity against intracellular microbes. It is predominantly responsible for the antiviral activities of the interferons.
Interleukin-1: One of the most important immune response modifying interleukins. The predominant function is to enhance the activation of T-cells in response to allergens.
Interleukin-2: Promotes the proliferation and differentiation of other immune cells and potentiates apoptotic death of antigen-activated T-cells.
Interleukin-6: Principle function is to augment the responses of immune cells to other cytokines. It is also the primary inducer of the acute phase response in the liver.
Lactoferrin: Binds iron and competes with microorganisms for it. Found to have antibacterial, antiviral, antifungal, anti-inflammatory, antioxidant and immunomodulatory activities.
Lactoperoxidase: Kills bacteria by oxidative mechanisms. When combined with hydrogen peroxide and thiocyanate, both of which are naturally distributed in human tissues, it forms a potent natural antibacterial system.
Lysozyme: Protects us from bacterial infection. It is a small enzyme that attacks the protective cell walls of bacteria.
Proline-Rich Polypeptide (PRP): Shown to support the thymus gland, and may help calm an overactive immune system and stimulate an underactive immune system.
Studies have shown that gastric and small intestinal injury caused by indomethacin can be reduced by colostrum?GUT 1999; 44: 653-658
Immune factors and growth factors are the primary components of colostrum. Bovine colostrum performs the following roles in the protection of the gastrointestinal tract: maintains integrity of mucosa, protects against intestinal permeability, aids local immunity, systemic immunity and antigen handling. It has also been used in treatment as well as prevention of NSAID-induced gut injury.?Indian J Pediatr. 2005 Jul; 72(7):579-81
Insulin -like growth factor, IGF-I, has been investigated as a potential treatment modality for a range of acute bowel disorders in which accelerated intestinal repair and epithelial regrowth are desirable.?J Nutr. 2003 Jul; 133(7):2109-12
Various bioactive and regulatory components, including IGF-I, exert intestinal effects. Colostrum extract, which contained bioactive components, such as IGF-I, enhanced intestinal villus size.?Journal of Dairy Science Vol. 86, No. 5, 2003
Bjarnason, I., Zanelli, G., Smith, T. et al. (1987) Non- steroidal anti-in?ammatory drug induced intestinal in?ammation in humans. Gastroenterology 93, 480ń489
Bjarnason, I. (1988) Non-steroidal anti-in?ammatory drug induced small intestinal in?ammation in man. In Recent Advances in Gastroenterology (Pounder, R., ed.), pp. 23ń46, Churchill Livingstone Press, London
Morris, J., Madhok, R., Sturrock, R. D., Capell, H. A. and Mackenzie, J. F. (1991) Enteroscopic diagnosis of small bowel ulceration in patients receiving non steroidal anti-inflammatory drugs. Lancet 337, 520
Pastuszak, A. L., Schuler, L., Speck-Martin, C. E. et al. (1998) Use of misoprostol during pregnancy and Mobius' syndrome in infants. N. Engl. J. Med. 338, 1881ń1885
Xu, R. J. (1996) Development of the newborn GI tract and its relation to colostrum}milk intake : a review. Reprod. Fertil. Dev. 8, 35ń48
Xanthou, M., Bines, J. and Walker, W. A. (1995) Human milk and intestinal host defence in newborns : an update. Adv. Paediatr. 42, 171ń208
Playford, R. J., Floyd, D. N., Macdonald, C. E., Calnan, D. P., Adenekan, R. O., Johnson, W., Goodlad, R. A. and Marchbank, T. (1999) Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44,
Bjarnason, I., Macpherson, A. and Hollander, D. (1995) Intestinal permeability : an overview. Gastroenterology
S—rensen, S., Proud, F. J., Adam, A., Rutgers, H. C. and Batt, R. M. (1993) A novel HPLC method for the simultaneous quanti?cation of monosaccharides used in tests of intestinal function and permeability. Clin. Chim. Acta 221, 115ń125
Hardy, M. R., Townsend, R. R. and Lee, Y. C. (1998) Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. Anal. Biochem. 170, 54ń62
Bjarnason, I. (1994) Intestinal permeability. Gut Suppl. 1, S18ńS22
Tibble, J. A., Sigthorsson, G., Foster, R. et al. (1999) High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 45, 363ń366
Greco, L., D'Adamao, G., Truscelli, A., Parrilli, G., Mayer, M. and Budillon, G. (1991) Intestinal permeability after single dose gluten challenge in coeliac disease. Arch. Dis. Child. 66, 870ń872
Koltun, W. A., Tilberg, A. F., Page, M. J. and Poritz, L. S. (1998) Bowel permeability is improved in Crohn's disease after ileocolectomy. Dis. Colon Rectum 41, 687ń690
Bjarnason, I., Williams, P., Smethurst, P., Peters, T. J. and Levi, A. J. (1986) The effect of NSAIDs and prostaglandins on the permeability of the human small intestine. Gut 27, 1292ń1297
McCarthy, D. (1989) Nonsteroidal antiin?ammatory drug- induced ulcers : Management by traditional therapies. Gastroenterology 96, 662ń674
Larkai, E. N., Smith, J. L., Lidsky, M. D. and Graham, D. Y. (1987) Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am. J. Gastroenterol. 82, 1153ń1158
Morris, A. J., Wasson, L. A. and MacKenzie, J. F. (1992) Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33, 887ń889
Bjarnason, I., Hayllar, J., Macpherson, A. J. and Russell, A. S. (1993) Side effects of nonsteroidal anti-in?ammatory drugs on the small and large intestine in humans. Gastroenterology 104, 1832ń1847
Bjarnason, I., Zanelli, G., Prouse, P., Smethurst, P., Smith, T., Levi, S., Gumpel, M. J. and Levi, A. J. (1987) Blood and protein loss via small intestinal inflammation induced by nonsteroidal antiin?ammatory drugs. Lancet ii, 711ń714
Stack, W. A., Hawkey, G. M., Atherton, J. C., Logan, R. F. and Hawkey, C. J. (1999) Interaction of risk factors for peptic ulcer bleeding. Gastroenterology 116, G0419
Stack, W. A., Hawkey, G. M., Logan, R. F. and Hawkey, C. J. (1999) Low dose aspirin use and past history as the main determinants of site-speci?c ulcer bleeding. Gastroenterology 116, G1392